Taken all the above indicated that CEBPB and FGFR2 were differentially elevated in the bile duct cells of a sub-group of CC patients, and that elevated expression of FGFR2 and CEBPB may contribute to cancer development in CC. The gene discussed is FGFR2; the disease is cholangiocarcinoma.